An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid
Janus Kinase Inhibitors Represent New Tool to Slow Rheumatoid Arthritis
Physicians at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco report on studies about JAK inhibitors as targeted immunomodulators and disease-modifying therapies in RA
Rheumatology Research Foundation Grant Supports Medical School Curriculum Study
Funding aimed at teaching future physicians, rheumatologists clinical decision-making skills
Letters: UCLA Study on HLA-B27 Link with Ankylosing Spondylitis at Forefront
Researchers Scholosstein et al were first to connection HLA antigens to the inflammatory disease, not Brewerton et al as reported [The Rheumatologist, May 2014]
Rheumatologists May Help Patients with Rheumatoid Arthritis Overcome Obstacles to Sex
By asking about their sexual relationships, rheumatologists can improve quality of patients’ love lives
Aggregated Neutrophils Limit Inflammation
A new study suggests understanding this antiinflammatory pathway may lead to new immunomodulatory therapy for resolving inflammation
Rheumatology Drug Updates, Trials, Safety Data
Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know
ACR Travel Grants Encourage Collaboration, Research in Rheumatology
Grant recipients who attended the 34th annual European Workshop for Rheumatology Research recall conference highlights, connecting with overseas colleagues
Rheumatology Research Foundation’s Campaign to Advance Patient Care Ahead of Schedule
After three years, the Foundation’s Journey to Cure initiative to recruit and train new rheumatologists has achieved 78% of its $60 million, five-year goal
Why Tweaking Molecular Structures Can Be Hazardous to Our Health
The rise and fall of rofecoxib and valdecoxib demonstrate the need for caution in new drug development
- « Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 77
- Next Page »